Hemagglutinin (347-367)[E4G,E7A]-CAP7 (1-16); N-E5L-sC18

General Information


DRACP ID  DRACP03735

Peptide Name   Hemagglutinin (347-367)[E4G,E7A]-CAP7 (1-16); N-E5L-sC18

Sequence  GLLEALAELLEGLRKRLRKFRNKIKEK

Sequence Length  27

UniProt ID  P25230 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C145H257N45O37

Absent amino acids  CDHMPQSTVWY

Common amino acids  L

Mass  368686

Pl  11.29

Basic residues  9

Acidic residues  4

Hydrophobic residues  11

Net charge  5

Boman Index  -7347

Hydrophobicity  -67.78

Aliphatic Index  122.96

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27713223

Title  Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12031

DRACP is developed by Dr.Zheng's team.